“A group of public health organizations said on Friday they were concerned that industries selling fatty foods, alcohol and cigarettes could hijack a United Nations meeting on how to tackle chronic disease in order to protect their own interests,” Reuters reports. “In a letter to the Lancet medical journal, more than 140 international health organizations and campaign groups said the United Nations should ensure industry lobby groups are not able to manipulate the September 19-20 meeting and its outcome,” writing, “There are clear conflicts for the corporations that contribute to and profit from the sales of alcoholic beverages, foods with high fat, salt, and sugar contents, and tobacco products — all of which are important causes of [non-communicable diseases (NCDs)],” according to the news service (Kelland, 9/15).
Non Communicable Disease/Chronic Disease
NCD Draft Declaration Lacks Specific Targets, Calls For Nations To Adopt Recommendations For Reducing Chronic Disease Deaths
“World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable ‘lifestyle’ diseases,” including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), “amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries,” the Guardian reports. “The scale and disastrous potential of these diseases has led the U.N. to call only its second high-level summit on a health issue on Monday — the first was over AIDS in 2001. Months of negotiation have led to a draft declaration [.pdf] that will be signed at the summit,” the newspaper writes (Boseley, 9/16).
Low-income countries “could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday” in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports (Kelland, 9/19).
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York “are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices,” James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece. “By continuing to assert that the Doha Declaration is in fact limited in various ways, U.S. and European trade negotiators have tried to discourage the granting of compulsory licenses on patents for high-priced drugs for cancer and other non-communicable diseases,” he continues, before outlining a proposal called the “cancer prize approach” that would de-link drug prices from research and development incentives.
The New York Times describes how, as the U.N. begins its meeting on non-communicable diseases (NCDs), Chinese and Indian generic drug makers “say they are on the verge of selling cheaper copies” of costly biotech medications used to treat cancers, diabetes, arthritis and other chronic illnesses. “Their entry into the market in the next year — made possible by hundreds of millions of dollars invested in biotechnology plants — could not only transform the care of patients in much of the world but also ignite a counterattack by major pharmaceutical companies and diplomats from richer countries,” the newspaper writes.
The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs. The newspaper includes links to commentary from several attendees at the event, including Julio Frenk, dean of faculty at the Harvard School of Public Health; Nils Daulaire, director of the Office of Global Health Affairs, Department of Health and Human Services ; Ann Keeling, chief executive of the International Diabetes Federation and chair of the NCD Alliance; and Stephen Morrison, senior vice president of the Center for Strategic & International Studies, and director of the CSIS Global Health Policy Center, among others.
In this post in the Center for Global Development’s “Global Health Policy” blog, Amanda Glassman, director of global health policy and a research fellow at the center, writes that the “main outcome” of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) is an assignment for the WHO “to lead the…
PRI’s “The World” highlights the state of mental health care in Uganda in an examination of how the exclusion of mental health from the Millennium Development Goals (MDGs) has, according to some advocates, held back mental health as a global health issue. Julius Kayiira, director of Mental Health Uganda, an organization that provides social support, job training and care to people with mental illness, “says organizations like his face an enormous funding gap, and he blames that gap, in part, on the United Nations,” according to “The World.”
Foreign Affairs on Tuesday published an analysis examining the history of negotiations behind the political declaration approved on Monday by leaders attending the U.N. High-level Meeting on Non-Communicable Diseases (NCDs).
World leaders attending the first-ever U.N. High-level Meeting on Non-communicable Diseases (NCDs) kicked off the summit on Monday by “unanimously approving a ‘political declaration’ meant to stem a rising tide of [NCDs], now the world’s leading killer,” CNN reports (Ariosto, 9/19). The declaration “call[s] for a multi-pronged campaign by governments, industry and civil society to set up by 2013 the plans needed to curb the risk factors behind the four groups of NCDs — cardiovascular diseases, cancers, chronic respiratory diseases and diabetes,” according to the U.N. News Centre.